Effectiveness and Safety of BIO-11006 Inhalation Solution to Treat the Overproduction of Mucus and Inflammation in COPD
Clinical trial NCT00648245 · COMPLETED
Trial details
- NCT number
- NCT00648245
- Sponsor
- BioMarck Pharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2010-07-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.